Gossamer Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$179,817,000 over the previous period. Total operating expenses were $183,759,000.

Profit Margin

Gossamer Bio, Inc. (NASDAQ:GOSS): Profit margin
2016 0 -83K
2017 0 -6.77M
2018 0 -146.96M
2019 0 -180.81M
2020 0 -251.58M
2021 0 -249.07M
2022 0 -240.22M
2023 0 -179.81M

GOSS Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
00000000
Cost of revenue
4.38M4.42M5.16M4.26M3.08M000
Gross profit
-4.38M-4.42M-5.16M-4.26M-3.08M000
Operating exp.
Research and development
145.30M170.91M170.26M160.85M143.40M55.28M891K0
Selling and marketing
00000000
Total operating expenses
183.75M218.52M216.04M210.58M182.53M99.33M1.15M83K
Operating income
-183.75M-218.59M-216.12M-233.96M-186.13M-148.99M-6.65M-83K
Other income (expenses), net
3.94M-10.78M-17.88M-9.39M5.83M-49.34M-118K0
Income before tax
-179.81M-229.37M-234.00M-243.36M-180.30M-146.96M-6.77M-83K
Income tax expense
010.85M15.07M8.22M511K2.03M-5.38M0
Net income
-179.81M-240.22M-249.07M-251.58M-180.81M-146.96M-6.77M-83K
Earnings per share
Basic EPS
-1.18-2.84-3.33-3.67-3.3-2.43-0.27-0.00
Diluted EPS
-1.18-2.84-3.33-3.67-3.3-2.43-0.27-0.00
Data sourceData sourceData sourceData sourceData sourceData source